Parse

See where your brand stands in AI recommendations.

Products

  • Brands
  • Markets
  • Work with us
  • Pricing

Resources

  • Research
  • Methodology
  • Blog
  • MCP

© 2026 Parse. All rights reserved.

LegalPrivacy PolicyTerms of Service
Parse
Pricing
Sign inCheck your brand
  1. Brands
  2. Emyra
BrandsEmyra

Emyra in AI answers

Follow this brand

Data as of Sep 21, 2026 · Based on 3,332,371 AI responses across 10,526 prompts · See how Parse measures this

Emyra logoEmyraemyra.com · Low evidence
Low evidence

Emyra is a medication intelligence platform that integrates pharmacogenomics with real-time medication data to inform prescribing decisions at the point of care. It unifies patient genetic profiles, medication history, drug-gene interactions, clinical evidence, and patient-reported data to provide clear, actionable guidance—without requiring PGx expertise—and offers side-by-side medication comparisons and risk flags. The system is designed to fit into clinicians' workflows and support safer, more personalized care across the full care continuum, from prescription to patient conversations at home.

Parse Score

31

Explore

Top cited sources

  • emyra.com (opens in a new tab)Owned67%
  • myclavis.ai (opens in a new tab)33%

Questions

No contexts measured yet.

  • Named in
  • 14% · 2 engines

    Excerpts where Emyra appeared in the AI's answer

    ChatGPT Search · excerpt
    Emyra — Combines pharmacogenomic data with medication history and drug-interaction information
    ChatGPT Search · excerpt
    Emyra — Focuses on bringing pharmacogenomic information into the prescribing workflow